Ornithine decarboxylase activity in cerebral post-ischemic reperfusion damage: effect of methionine sulfoximine

Neurochem Res. 1997 Sep;22(9):1145-50. doi: 10.1023/a:1027321420075.

Abstract

Excessive activation of glutamate receptors via the N-methyl-D-aspartate (NMDA) subtype appears to play a role in the sequence of cellular events which lead to irreversible ischemic damage to neurons. Furthermore, NMDA receptor activation induces a stimulation of ornithine decarboxylase (ODC), the rate-limiting enzyme for polyamine (PA) biosynthesis. In order to better understand the role of PA we have measured ODC activity and the effect of methionine sulfoximine (MSO), a molecule able to stimulate ODC, on a model of transient cerebral ischemia. There was a significant increase in ODC activity in the rat cerebral cortex during post-ischemic reperfusion. The treatment with MSO induced a significant decrease in cerebral glutamine synthetase activity accompanied by a marked increase in ODC activity. In MSO-pretreated rats there was a significant decrease in the survival rate when compared to untreated ischemic rats.

MeSH terms

  • Animals
  • Cerebral Cortex / blood supply
  • Cerebral Cortex / drug effects*
  • Male
  • Methionine Sulfoximine / pharmacology*
  • Ornithine Decarboxylase / metabolism*
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / enzymology

Substances

  • Methionine Sulfoximine
  • Ornithine Decarboxylase